These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 31255367)
1. Role of vitamin D in risk factors of patients with type 2 diabetes mellitus. Zhang Q; Wu Y; Lu Y; Fei X Med Clin (Barc); 2020 Mar; 154(5):151-156. PubMed ID: 31255367 [TBL] [Abstract][Full Text] [Related]
2. Association of 25-hydroxyvitamin D, lipoprotein-associated phospholipase A2 and asymptomatic coronary artery disease in patients with type 2 diabetes mellitus. Zhang Q; Zhang QQ; He JJ; Dong SQ; Lu Y Diabetes Res Clin Pract; 2024 Jun; 212():111681. PubMed ID: 38677367 [TBL] [Abstract][Full Text] [Related]
3. Influence of obesity and cardiometabolic makers on lipoprotein-associated phospholipase A2 (Lp-PLA2) activity in adolescents: the healthy young cross-sectional study. da Silva IT; Timm Ade S; Damasceno NR Lipids Health Dis; 2013 Feb; 12():19. PubMed ID: 23413990 [TBL] [Abstract][Full Text] [Related]
4. Lipoprotein-associated phospholipase A2 is a risk factor for diabetic kidney disease. Hu Y; Li TT; Zhou W; Lu TT; Li FF; Ding B; Liu BL; Xie XJ; Ma JH Diabetes Res Clin Pract; 2019 Apr; 150():194-201. PubMed ID: 30904742 [TBL] [Abstract][Full Text] [Related]
5. Differential expression of Lp-PLA2 in obesity and type 2 diabetes and the influence of lipids. Jackisch L; Kumsaiyai W; Moore JD; Al-Daghri N; Kyrou I; Barber TM; Randeva H; Kumar S; Tripathi G; McTernan PG Diabetologia; 2018 May; 61(5):1155-1166. PubMed ID: 29427237 [TBL] [Abstract][Full Text] [Related]
6. Relationship between plasma phospholipase A2 concentrations and lipoprotein subfractions in patients with stable coronary artery disease. Xu RX; Zhang Y; Li XL; Li S; Guo YL; Dong Q; Liu G; Li JJ Clin Chim Acta; 2015 Jun; 446():195-200. PubMed ID: 25934512 [TBL] [Abstract][Full Text] [Related]
7. Gender-related and PUFA-related differences in lipoprotein-associated phospholipase A2 levels in patients with type 2 diabetes and atherosclerotic cardiovascular disease. Hanarz M; Siniarski A; Gołębiowska-Wiatrak R; Nessler J; Malinowski KP; Gajos G Adv Clin Exp Med; 2024 Jun; 33(6):593-600. PubMed ID: 37747445 [TBL] [Abstract][Full Text] [Related]
8. 25-hydroxyvitamin D is associated with adiposity and cardiometabolic risk factors in a predominantly vitamin D-deficient and overweight/obese but otherwise healthy cohort. Mousa A; Naderpoor N; de Courten MPJ; Scragg R; de Courten B J Steroid Biochem Mol Biol; 2017 Oct; 173():258-264. PubMed ID: 28007531 [TBL] [Abstract][Full Text] [Related]
9. Lipoprotein-associated phospholipase A₂ activity is increased in patients with definite familial hypercholesterolemia compared with other forms of hypercholesterolemia. Mattina A; Rosenbaum D; Bittar R; Bonnefont-Rousselot D; Noto D; Averna M; Bruckert E; Giral P Nutr Metab Cardiovasc Dis; 2018 May; 28(5):517-523. PubMed ID: 29525223 [TBL] [Abstract][Full Text] [Related]
10. Effect of intensive insulin treatment on plasma levels of lipoprotein-associated phospholipase A Lin XH; Xu MT; Tang JY; Mai LF; Wang XY; Ren M; Yan L Lipids Health Dis; 2016 Nov; 15(1):203. PubMed ID: 27881128 [TBL] [Abstract][Full Text] [Related]
11. Relationship between Plasma Lipoprotein-Associated Phospholipase A2 Concentrations and Apolipoprotein in Stable Coronary Artery Disease Patients. Ling Y; Tang S; Cao Y; Fu C Dis Markers; 2020; 2020():8818358. PubMed ID: 33029257 [TBL] [Abstract][Full Text] [Related]
12. [Lipoprotein-associated phospholipase A2 serum levels in patients from different categories of cardiovascular risk]. Nozadze DN; Sergienko IV; Balakhonova TV; Semenova AE; Vlasik TN; Kukharchuk VV Kardiologiia; 2014; 54(3):57-63. PubMed ID: 25102750 [TBL] [Abstract][Full Text] [Related]
13. [Association of lipoprotein-associated phospholipase activity A2 with cardiovascular risk factors]. Acevedo M; Varleta P; Kramer V; Quiroga T; Prieto C; Parada J; Adasme M; Briones L; Navarrete C Rev Med Chil; 2013 Nov; 141(11):1382-8. PubMed ID: 24718463 [TBL] [Abstract][Full Text] [Related]
14. The correlation between lipoprotein associated phospholipase A Chen YH; Li WC; Chen YC; Yeh WC; Yu W; Hung HY; Jie XX; Chen JY Int J Immunopathol Pharmacol; 2021; 35():20587384211048562. PubMed ID: 34796753 [TBL] [Abstract][Full Text] [Related]
15. Hypovitaminosis D is associated with reductions in serum apolipoprotein A-I but not with fasting lipids in British Bangladeshis. John WG; Noonan K; Mannan N; Boucher BJ Am J Clin Nutr; 2005 Sep; 82(3):517-22. PubMed ID: 16155262 [TBL] [Abstract][Full Text] [Related]
16. The relationships between biological novel biomarkers Lp-PLA Chen Y; Wang S; Li J; Fu Y; Chen P; Liu X; Zhang J; Sun L; Zhang R; Li X; Liu L J Diabetes; 2024 Jul; 16(7):e13574. PubMed ID: 38924255 [TBL] [Abstract][Full Text] [Related]
17. Dose-response effects of marine omega-3 fatty acids on apolipoproteins, apolipoprotein-defined lipoprotein subclasses, and Lp-PLA2 in individuals with moderate hypertriglyceridemia. Skulas-Ray AC; Alaupovic P; Kris-Etherton PM; West SG J Clin Lipidol; 2015; 9(3):360-7. PubMed ID: 26073395 [TBL] [Abstract][Full Text] [Related]
18. Association between lipoprotein-associated phospholipase A2 and 25-hydroxy-vitamin D on early stage diabetic kidney disease in patients with type-2 diabetes mellitus. Zhang Z; Qian X; Sun Z; Cheng C; Gu M Heliyon; 2024 Aug; 10(16):e35635. PubMed ID: 39220926 [TBL] [Abstract][Full Text] [Related]